FDA Requests Strengthened Warnings For Extended-Release Morphine Avinza

The labeling change request coincides with the withdrawal of Purdue's extended-release hydromorphone product Palladone due to the potential for serious alcohol-related adverse events. Ligand will intensify warnings about alcohol use with Avinza while further information on the risk is gathered.